(Q50682265)

English

Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health.

scientific article published in September 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health. (English)

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

1 reference

based on heuristic

inferred from title

Hepatitis B vaccine

1 reference

based on heuristic

inferred from title

author name string

C M Wilson

1

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

J H Ellenberg

2

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

M K Sawyer

3

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

M Belzer

4

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

P A Crowley-Nowick

5

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

A Puga

6

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

D C Futterman

7

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

L Peralta

8

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

Adolescent Medicine HIV/AIDS Research Network

9

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

publication date

1 September 2001

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

Journal of Adolescent Health

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

29

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

3 Suppl

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

123-129

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

Hepatitis B: Evolving Epidemiology and Implications for Control

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Surveillance and prevention of hepatitis B virus transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to hepatitis B immunization by infants exposed to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired response to hepatitis B vaccine in HIV infected children

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune response to hepatitis B vaccine in parenteral drug abusers

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: an indicator of poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired response to recombinant hepatitis B vaccine in HIV-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: design, methods, and selected characteristics of participants

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The REACH (Reaching for Excellence in Adolescent Care and Health) project: study design, methods, and population profile

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents. Adolescent Medicine HIV/AIDS Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: retention of naive T lymphocytes in HIV-infected adolescents. The Adolescent Medicine HIV/AIDS Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Short Communication: Relationship of CD4+ T Cell Counts and HIV Type 1 Viral Loads in Untreated, Infected Adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevalence of anergy in human immunodeficiency virus-infected adolescents and the association of delayed-type hypersensitivity with subject characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B Vaccine Administered to Children and Adolescents at Yearly Intervals

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of time to completion of the hepatitis B vaccination series among adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Compliance of hepatitis B vaccination in patients presenting to a teenage clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: findings of the REACH Study. Adolescent Medicine HIV/AIDS Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load

1 reference

https://api.crossref.org/works/10.1016%2FS1054-139X%2801%2900278-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1054-139X(01)00278-6

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11530313

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50682265&oldid=1566763382"